Researchers estimate trends in vaping among adults in the United Kingdom who have not smoked regularly.
Rucaparib camsylate by Pharmaand for Renal Cell Carcinoma: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes